Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000286671 | SCV000343760 | benign | not specified | 2016-07-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000286671 | SCV000516336 | benign | not specified | 2016-03-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001660556 | SCV001875837 | benign | Asphyxiating thoracic dystrophy 3 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002059265 | SCV002362492 | benign | Jeune thoracic dystrophy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000286671 | SCV001955130 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000286671 | SCV001968263 | benign | not specified | no assertion criteria provided | clinical testing |